|
|
||||||||
Articles |
OBJECTIVE: To determine the type of recurrent pregnancy loss associated with antiphospholipid antibodies. METHODS: This was a retrospective analysis of women who had two or more pregnancy losses and who were tested for antiphospholipid antibodies. The specific type of pregnancy losses were determined in patients with and without antiphospholipid antibodies. RESULTS: In our highly selected referral population, 76 of 366 women (21%) tested positive for lupus anticoagulant or anticardiolipin antibodies of 20 or more immunoglobulin-G phospholipid antibody units. Pregnancy loss occurred in 280 of 333 (84%) prior pregnancies in women with and 1240 of 1479 (84%) without antiphospholipid antibodies. However, 50% of pregnancy losses in women with antiphospholipid antibodies were fetal deaths, compared with less than 15% in women who were antiphospholipid antibody-negative. More than 80% of women with antiphospholipid antibodies had at least one fetal death, compared with less than 25% of women without (P < .001). The specificity of fetal death for the presence of antiphospholipid antibodies in patients with recurrent pregnancy loss was 76%. In contrast, two or more early first-trimester losses without fetal death had a specificity of only 6% for antiphospholipid antibodies. CONCLUSION: Fetal death is more characteristic of the type of loss experienced by patients with recurrent pregnancy loss than early first-trimester pregnancy loss in women with antiphospholipid antibodies.
This article has been cited by other articles:
![]() |
S. M. Nelson and I. A. Greer The potential role of heparin in assisted conception Hum. Reprod. Update, November 1, 2008; 14(6): 623 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cervera and J. Balasch Bidirectional effects on autoimmunity and reproduction Hum. Reprod. Update, May 22, 2008; (2008) dmn013v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Reddy Prediction and Prevention of Recurrent Stillbirth Obstet. Gynecol., November 1, 2007; 110(5): 1151 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sabatini, M. Torricelli, V. Scaccia, D. Fineschi, M. Pescaglini, L. Gasparri, P. Florio, and F. Petraglia Increased Plasma Concentrations of Antiprothrombin Antibodies in Women with Recurrent Spontaneous Abortions Clin. Chem., February 1, 2007; 53(2): 228 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Silver Fetal Death Obstet. Gynecol., January 1, 2007; 109(1): 153 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lim, M. A. Crowther, and J. W. Eikelboom Management of Antiphospholipid Antibody Syndrome: A Systematic Review JAMA, March 1, 2006; 295(9): 1050 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Bick and D. Hoppensteadt Recurrent Miscarriage Syndrome and Infertility Due to Blood Coagulation Protein/Platelet Defects: A Review and Update Clinical and Applied Thrombosis/Hemostasis, January 1, 2005; 11(1): 1 - 13. [Abstract] [PDF] |
||||
![]() |
M Blank and Y Shoenfeld Antiphosphatidylserine antibodies and reproductive failure Lupus, September 1, 2004; 13(9): 661 - 665. [Abstract] [PDF] |
||||
![]() |
A. E. Frias Jr, R. A. Luikenaar, A. E. Sullivan, R. M. Lee, T F. Porter, D W. Branch, and R. M. Silver Poor Obstetric Outcome in Subsequent Pregnancies in Women With Prior Fetal Death Obstet. Gynecol., September 1, 2004; 104(3): 521 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hurtado, R. Montes, J.-C. Gris, M. L. Bertolaccini, A. Alonso, M. A. Martinez-Gonzalez, M. A. Khamashta, K. Fukudome, D. A. Lane, and J. Hermida Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death Blood, September 1, 2004; 104(5): 1369 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Hanly Antiphospholipid syndrome: an overview Can. Med. Assoc. J., June 24, 2003; 168(13): 1675 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Levine, D. W. Branch, and J. Rauch The Antiphospholipid Syndrome N. Engl. J. Med., March 7, 2002; 346(10): 752 - 763. [Full Text] [PDF] |
||||
![]() |
I. Martinelli, E. Taioli, I. Cetin, A. Marinoni, S. Gerosa, M. V. Villa, M. Bozzo, and P. M. Mannucci Mutations in Coagulation Factors in Women with Unexplained Late Fetal Loss N. Engl. J. Med., October 5, 2000; 343(14): 1015 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Bick Recurrent Miscarriage Syndrome due to Blood Coagulation Protein/Platelet Defects: Prevalence, Treatment and Outcome Results Clinical and Applied Thrombosis/Hemostasis, July 1, 2000; 6(3): 115 - 125. [Abstract] [PDF] |
||||
![]() |
J Carbone, M Orera, M Rodriguez-Mahou, C Rodriguez-Perez, S Sanchez-Ramon, E Seoane, J J Rodriguez, J M Zabay, and E Fernandez-Cruz Immunological abnormalities in primary APS evolving into SLE: 6 years follow-up in women with repeated pregnancy loss Lupus, May 1, 1999; 8(4): 274 - 278. [Abstract] [PDF] |
||||
![]() |
A. LYNCH, T. BYERS, W. EMLEN, D. RYNES, S. M. SHETTERLY, and R. F. HAMMAN Association of Antibodies to Beta2-Glycoprotein 1 With Pregnancy Loss and Pregnancy-Induced Hypertension: A Prospective Study in Low-Risk Pregnancy Obstet. Gynecol., February 1, 1999; 93(2): 193 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hill Immunotherapy for Recurrent Pregnancy Loss: "Standard of Care of Buyer Beware" Reproductive Sciences, November 1, 1997; 4(6): 267 - 273. [PDF] |
||||
![]() |
Antiphospholipid Antibodies and Type of Pregnancy Loss Journal Watch Women's Health, May 1, 1996; 1996(501): 21 - 21. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |